EUVIMEDEUVIMED entdecken
Crossref

An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action

Kensuke Kawamoto iD, Yukako Shimotsuma, Keiko Maeda, Kohei Matsunaga, Hiroyuki Asano, Samuel M Cohen iD, Tomoya Yamada iD

Archives of Toxicology · 2025

DOI: 10.1007/s00204-025-04099-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Kensuke Kawamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan. kawamotok@sc.sum…. Hauptthemen laut MEDLINE: Fungicides, Industrial, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a carcinogenicity study with CD-1 mice exposed to pyridachlometyl (dietary dose levels: 0, 700, 2000, and 7000 ppm), a combined incidence of hepatocellular adenoma and carcinoma was increased in male mice at doses ≥ 2000 ppm, but not in female mice. We evaluated the mode of action (MOA) of pyridachlometyl-induced liver tumor formation in male mice and its relevance to humans. Pyridachlometyl was found to be neither genotoxic, cytotoxic, immunosuppressive, nor hormone-mediated based on a series of toxicity studies. Data from general toxicity studies suggested that the MOA involves activation of the nuclear receptor constitutive androstane receptor (CAR), leading to a pleiotropic response including altered gene expression specific to CAR activation, increased hepatocyte proliferation, clonal expansion resulting in altered hepatic foci, and ultimately liver tumor formation. Short-term in vivo MOA studies in CD-1 mice showed that pyridachlometyl significantly increased liver weight, incidence of centrilobular hepatocyte hypertrophy, Cyp2b10 and Cyp3a11 mRNA levels and their enzyme activities, and hepatocyte replicative DNA synthesis, all in a dose-dependent manner. These effects were reversible upon cessation of treatment and were attenuated in CAR/PXR knockout mice. Pyridachlometyl induced human CYP2B6 and CYP3A4 mRNAs but did not increase replicative DNA synthesis in either cultured human hepatocytes or human hepatocytes in chimeric mice (PXB-mice). Overall, these data strongly support that the MOA for pyridachlometyl-induced hepatocellular tumors in male mice is via activation of CAR, indicatiing that the liver tumor formation observed in male mice is not relevant to humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fungicides, IndustrialLiver NeoplasmsCarcinoma, HepatocellularLiver Neoplasms, ExperimentalAdenoma, Liver CellAnimalsMaleHumansMiceReceptors, Cytoplasmic and NuclearFemaleConstitutive Androstane ReceptorHepatocytesDose-Response Relationship, DrugLiverCytochrome P-450 CYP3AAryl Hydrocarbon HydroxylasesCell ProliferationCytochrome P450 Family 2Steroid Hydroxylases

Stichwörter der Autor:innen

CAR/PXRCell proliferationHepatocellular tumorsHuman relevanceHumanized mouseMode of action

Substanzen

Receptors, Cytoplasmic and NuclearConstitutive Androstane ReceptorFungicides, IndustrialCytochrome P-450 CYP3AAryl Hydrocarbon HydroxylasesCyp2b10 protein, mouseCytochrome P450 Family 2Steroid Hydroxylases

Autor:innen und Institutionen

  • Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan. kawamotok@sc.sumitomo-chem.co.jp.
  • Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-8558, Japan.
  • Department of Pathology, Microbiology, and Immunology, Buffett Cancer Center, Sylvia Havlik Centennial Professor of Oncology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE, 68198-3135,…

ORCID-Profile: Kensuke Kawamoto, Samuel M Cohen, Tomoya Yamada

Zitieren

APA

Kawamoto, K., Shimotsuma, Y., Maeda, K., Matsunaga, K., Asano, H., Cohen, S. M., & Yamada, T. (2025). An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04099-9

Vancouver

Kawamoto K, Shimotsuma Y, Maeda K, Matsunaga K, Asano H, Cohen SM, et al. An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action. Archives of Toxicology. 2025. doi:10.1007/s00204-025-04099-9

BibTeX
@article{Kawamoto2025,
  author = {Kawamoto, Kensuke and Shimotsuma, Yukako and Maeda, Keiko and Matsunaga, Kohei and Asano, Hiroyuki and Cohen, Samuel M and Yamada, Tomoya},
  title = {An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action},
  journal = {Archives of Toxicology},
  year = {2025},
  doi = {10.1007/s00204-025-04099-9}
}
Kostenlos starten →